206 related articles for article (PubMed ID: 20979633)
21. A qualitative study of the feasibility and community perception on the effectiveness of artemether-lumefantrine use in the context of home management of malaria in south-west Nigeria.
Ajayi IO; Falade CO; Olley BO; Yusuf B; Gbotosho S; Iyiola T; Olaniyan O; Happi C; Munguti K; Pagnoni F
BMC Health Serv Res; 2008 Jun; 8():119. PubMed ID: 18513447
[TBL] [Abstract][Full Text] [Related]
22. Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania.
Kabanywanyi AM; Lengeler C; Kasim P; King'eng'ena S; Schlienger R; Mulure N; Genton B
Malar J; 2010 Feb; 9():48. PubMed ID: 20149235
[TBL] [Abstract][Full Text] [Related]
23. Cluster randomized trial of text message reminders to retail staff in tanzanian drug shops dispensing artemether-lumefantrine: effect on dispenser knowledge and patient adherence.
Bruxvoort K; Festo C; Kalolella A; Cairns M; Lyaruu P; Kenani M; Kachur SP; Goodman C; Schellenberg D
Am J Trop Med Hyg; 2014 Oct; 91(4):844-853. PubMed ID: 25002300
[TBL] [Abstract][Full Text] [Related]
24. Health worker performance in the management of paediatric fevers following in-service training and exposure to job aids in Kenya.
Wasunna B; Zurovac D; Bruce J; Jones C; Webster J; Snow RW
Malar J; 2010 Sep; 9():261. PubMed ID: 20849650
[TBL] [Abstract][Full Text] [Related]
25. Awareness of anti-malarial policy and malaria treatment practices of patent medicine vendors in three Nigerian states.
Oladepo O; Brieger W; Adeoye B; Lawal B; Peters DH
Afr J Med Med Sci; 2011 Dec; 40(4):345-52. PubMed ID: 22783684
[TBL] [Abstract][Full Text] [Related]
26. Physical and chemical stability of expired fixed dose combination artemether-lumefantrine in uncontrolled tropical conditions.
Bate R; Tren R; Hess K; Attaran A
Malar J; 2009 Feb; 8():33. PubMed ID: 19243589
[TBL] [Abstract][Full Text] [Related]
27. A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013.
Kioko U; Riley C; Dellicour S; Were V; Ouma P; Gutman J; Kariuki S; Omar A; Desai M; Buff AM
Malar J; 2016 Jul; 15(1):359. PubMed ID: 27406179
[TBL] [Abstract][Full Text] [Related]
28. Quality of malaria case management at outpatient health facilities in Angola.
Rowe AK; de León GF; Mihigo J; Santelli AC; Miller NP; Van-Dúnem P
Malar J; 2009 Dec; 8():275. PubMed ID: 19954537
[TBL] [Abstract][Full Text] [Related]
29. Changes in health workers' malaria diagnosis and treatment practices in Kenya.
Juma E; Zurovac D
Malar J; 2011 Jan; 10():1. PubMed ID: 21214892
[TBL] [Abstract][Full Text] [Related]
30. Budget Impact Analysis of Using Dihydroartemisinin-Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania.
Mori AT; Norheim OF; Robberstad B
Pharmacoeconomics; 2016 Mar; 34(3):303-14. PubMed ID: 26521172
[TBL] [Abstract][Full Text] [Related]
31. Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia.
Barnes KI; Chanda P; Ab Barnabas G
Malar J; 2009 Oct; 8 Suppl 1(Suppl 1):S8. PubMed ID: 19818175
[TBL] [Abstract][Full Text] [Related]
32. Perceptions and drivers of healthcare provider and drug dispenser practices for the treatment of malaria in pregnancy in the context of multiple first-line therapies in western Kenya: a qualitative study.
Osoro CB; Dellicour S; Ochodo E; Young T; Ter Kuile FO; Gutman JR; Hill J
Malar J; 2023 Sep; 22(1):274. PubMed ID: 37710229
[TBL] [Abstract][Full Text] [Related]
33. Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities.
Goodman C; Kachur SP; Abdulla S; Mwageni E; Nyoni J; Schellenberg JA; Mills A; Bloland P
Trop Med Int Health; 2004 Jun; 9(6):655-63. PubMed ID: 15189455
[TBL] [Abstract][Full Text] [Related]
34. Coartem: the journey to the clinic.
Premji ZG
Malar J; 2009 Oct; 8 Suppl 1(Suppl 1):S3. PubMed ID: 19818170
[TBL] [Abstract][Full Text] [Related]
35. Malaria case-management under artemether-lumefantrine treatment policy in Uganda.
Zurovac D; Tibenderana JK; Nankabirwa J; Ssekitooleko J; Njogu JN; Rwakimari JB; Meek S; Talisuna A; Snow RW
Malar J; 2008 Sep; 7():181. PubMed ID: 18803833
[TBL] [Abstract][Full Text] [Related]
36. Perceptions and utilization of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine in young children in the Chikhwawa District of Malawi: a mixed methods study.
Ewing VL; Terlouw DJ; Kapinda A; Pace C; Richards E; Tolhurst R; Lalloo DG
Malar J; 2015 Jan; 14():13. PubMed ID: 25605477
[TBL] [Abstract][Full Text] [Related]
37. An assessment of the knowledge, practices and resources during the delivery of malaria health care services among private health care practitioners: a cross section study in the Mid-Western Region of Uganda.
Wanzira H; Tumwine D; Bukoma P; Musiime A; Biculu J; Ediamu T; Gudoi S; Tibenderana JK; Mulebeke R; Nantanda R; Achan J
BMC Health Serv Res; 2021 Aug; 21(1):788. PubMed ID: 34376219
[TBL] [Abstract][Full Text] [Related]
38. Using mobile phone text messaging for malaria surveillance in rural Kenya.
Githinji S; Kigen S; Memusi D; Nyandigisi A; Wamari A; Muturi A; Jagoe G; Ziegler R; Snow RW; Zurovac D
Malar J; 2014 Mar; 13():107. PubMed ID: 24642130
[TBL] [Abstract][Full Text] [Related]
39. Rational dispensing and use of artemether-lumefantrine during pregnancy in Dar es Salaam, Tanzania.
Kamuhabwa AR; Mnyusiwalla F
Tanzan J Health Res; 2011 Apr; 13(2):106-13. PubMed ID: 25566607
[TBL] [Abstract][Full Text] [Related]
40. Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children.
Abdulla S; Sagara I
Malar J; 2009 Oct; 8 Suppl 1(Suppl 1):S7. PubMed ID: 19818174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
